Worth reading
49Recurring
Scored from 5 of 6 sectionsDirection
Deterioration
Direction inferred from the company’s description.Scale
-11.9
Year-on-year change in revenue (%)Wording
Conditional
How definitive the wording is.Results for this period
First quarter2024年4月1日〜2024年6月30日Non-consolidated (standalone)Japanese GAAPNet Sales1,492¥ millionYear on year -11.9%Progress 15.4%
Operating profit-88¥ million
Ordinary income-103¥ million
Net income attributable to owners of the parent-81¥ million
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share△2.87円
Financial position at period-end
Total assets12,941¥ million
of which net assets 10,431 ¥ millionEquity ratio 80.6%vs. prior year-end +6.0pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥9,660 million (YoY +5.7%)
Operating profit¥1,972 million (YoY +2.6%)
Ordinary income¥1,985 million (YoY +1.6%)
Net income¥1,380 million (YoY +2.3%)
Annual Dividend Forecast¥20 → ¥20（0.0%）
Factors Behind Changes in Business Performance
「コタエイジング バウンスアップ」の反動減により売上高が減少した一方、「コタ アイ ケア」の販売は堅調に推移した。販売費及び一般管理費は人件費等の増加により前年同期を上回った。
Disclosure regarding the going concern assumption
No applicable matters
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Material subsequent events自己株式の公開買付けにより、2024年7月5日付で普通株式471,115株を601,613千円で取得した。
Depreciation and amortization¥89,104 thousand
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingNo
Issued Shares at Period-End32,934,663
Treasury Shares at Period-End4,709,231
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Non-consolidated (standalone) |
| Period Covered | 2024年4月1日〜2024年6月30日 |
| Net Sales | ¥1,492 million (YoY -11.9%) |
| Operating profit | ¥-88 million |
| Ordinary income | ¥-103 million |
| Profit attributable to owners of the parent | ¥-81 million |
| Net income per share | △2.87円 |
| Equity ratio | End of the current fiscal period 80.6 / End of previous period 74.6 |
| Total assets | ¥12,941 million |
| Net assets | ¥10,431 million |
| Full-year earnings forecast | Net Sales ¥9,660 million (YoY +5.7%) / Operating profit ¥1,972 million (YoY +2.6%) / Ordinary income ¥1,985 million (YoY +1.6%) / Net income ¥1,380 million (YoY +2.3%) |
| Annual Dividend Forecast | ¥20 → ¥20（0.0%） |
| Depreciation and amortization | ¥89,104 thousand |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Material subsequent events | 自己株式の公開買付けにより、2024年7月5日付で普通株式471,115株を601,613千円で取得した。 |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 32,934,663 |
| Treasury Shares at Period-End | 4,709,231 |
| Factors Behind Changes in Business Performance | 「コタエイジング バウンスアップ」の反動減により売上高が減少した一方、「コタ アイ ケア」の販売は堅調に推移した。販売費及び一般管理費は人件費等の増加により前年同期を上回った。 |
Items this document does not state (15)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicySegment revenueSegment profitRegional salesOrders received and order backlogImpairment lossBreakdown of extraordinary income (loss)Changes in the scope of consolidation
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.昨年発売した「コタエイジング バウンスアップ」の反動減により売上高が前年同期を下回った。販売費及び一般管理費は人件費等の増加により前年同期を上回った。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.